サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1761085

幹細胞アッセイの世界市場

Stem Cell Assays

出版日
ページ情報
英文 193 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.41円
幹細胞アッセイの世界市場
出版日: 2025年07月02日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 193 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

幹細胞アッセイの世界市場は2030年までに77億米ドルに到達

2024年に29億米ドルと推定される幹細胞アッセイの世界市場は、2024年から2030年にかけてCAGR 17.9%で成長し、2030年には77億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである機器は、CAGR18.4％を記録し、分析期間終了時には61億米ドルに達すると予測されます。キットセグメントの成長率は、分析期間中CAGR 17.7％と推定されます。

米国市場は7億9,110万米ドルと推定、中国はCAGR16.4％で成長予測

米国の幹細胞アッセイ市場は、2024年に7億9,110万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに11億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは16.4%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ16.0％と15.1％と予測されています。欧州では、ドイツがCAGR約12.9%で成長すると予測されています。

世界の幹細胞アッセイ市場- 主要動向と促進要因のまとめ

幹細胞アッセイは創薬と開発にどのような革命をもたらしているか？

幹細胞アッセイは、再生医療、創薬、開発の分野において、細胞の挙動、分化、潜在的な治療用途に関する洞察を提供する重要なツールとして登場しました。これらのアッセイによって、研究者は幹細胞における薬剤候補の効力、有効性、毒性を評価することができ、前臨床研究に貴重なデータを提供することができます。個別化医療や再生治療に対する需要の高まりに伴い、幹細胞アッセイの使用は製薬およびバイオテクノロジー分野で急速に拡大しています。幹細胞アッセイは、ヒト疾患のモデル化、薬剤応答の予測、新規治療ターゲットのスクリーニングが可能であるため、次世代治療の推進に欠かせないものとなっています。さらに、毒性試験やハイスループットスクリーニングにおける幹細胞アッセイの採用が、研究機関やCRO（医薬品開発業務受託機関）全体での需要を促進しています。

どのような技術革新が幹細胞アッセイの将来を形成していますか？

技術の進歩は幹細胞アッセイの将来を大きく左右し、その精度、信頼性、拡張性を高めています。ハイコンテントスクリーニング（HCS）、自動イメージング、データ解析の統合により、より洗練され、頑健で再現性の高い幹細胞アッセイの開発が可能になっています。3D細胞培養、オルガノイド、マイクロ流体システムにおける革新は、生体内の条件を忠実に模倣した、より生理学的に適切なモデルを提供し、幹細胞アッセイの予測力を向上させています。さらに、CRISPR-Cas9遺伝子編集技術や人工多能性幹細胞（iPS細胞）の出現は、遺伝病、薬剤耐性、細胞治療の研究における幹細胞アッセイの範囲を拡大しつつあります。こうした技術革新は、精密医療や標的治療に対する需要の高まりに対応できる、より効率的でハイスループットかつコスト効率の高いアッセイプラットフォームへのシフトを促しています。

幹細胞アッセイ業界の成長をリードする市場セグメンテーションは？

幹細胞アッセイの種類には、生存率/細胞毒性アッセイ、増殖アッセイ、分化アッセイ、アポトーシスアッセイなどがあり、生存率/細胞毒性アッセイは、薬物毒性試験や安全性評価に広く使用されているため、最大の市場シェアを占めています。幹細胞アッセイの主なアプリケーションは、創薬および開発、再生医療、臨床研究、毒性試験など多岐にわたりますが、創薬および開発は、革新的で効果的な薬剤候補に対する需要が高いことから、重要なセグメントとなっています。幹細胞アッセイのエンドユーザーには、製薬・バイオテクノロジー企業、学術・研究機関、CROが含まれ、製薬・バイオテクノロジー企業は、研究開発および再生医療への多額の投資により市場を主導しています。地理的には、北米、欧州、アジア太平洋が幹細胞アッセイの最大市場であり、強力な研究インフラ、政府資金、個別化医療と細胞ベースの治療への関心の高まりがその原動力となっています。

幹細胞アッセイ市場の成長促進要因は？

幹細胞アッセイ市場の成長は、再生医療、個別化治療、標的創薬に対する需要の高まり、アッセイプラットフォーム、自動化、高含量スクリーニングの技術進歩、臨床試験、免疫療法、がん研究における幹細胞アッセイの採用増加など、いくつかの要因によってもたらされます。様々な研究および臨床アプリケーションにおいて、正確で再現性の高いハイスループットなソリューションを提供する必要性が、様々な分野において幹細胞アッセイの需要を牽引しています。3D細胞培養、オルガノイド、遺伝子編集、データ解析における技術革新は、アッセイ設計、イメージング、マルチプレキシングの進歩と相まって、幹細胞アッセイの性能、信頼性、市場性を高め、市場の成長を支えています。神経生物学、心血管研究、感染症、毒物学などにおける幹細胞アッセイの応用拡大、幹細胞の分化、特性評価、力価試験への重点の高まりは、市場関係者に新たな機会をもたらしています。さらに、多様な研究ニーズに対応する堅牢でコスト効率が高く、拡張性のある幹細胞アッセイソリューションの開発に注力していることが、幹細胞アッセイ市場の成長をさらに後押ししています。

セグメント

コンポーネント（装置、キット、サービス）;タイプ（生存性／細胞毒性、分化、分離・精製、細胞同定、増殖、機能、アポトーシス）;細胞タイプ（成体幹細胞、hESCs）;アプリケーション（再生医療、臨床研究、創薬開発）

調査対象企業の例（計44社）

  • Antria, Inc.
  • Applied StemCell, Inc.
  • Beike Biotechnology Co., Ltd.
  • BioGenCell
  • BioRestorative Therapies
  • Bio-Techne Corporation
  • Celltex Therapeutics
  • Century Therapeutics
  • Cynata Therapeutics Ltd.
  • Forever Labs, Inc.

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP15020

Global Stem Cell Assays Market to Reach US$7.7 Billion by 2030

The global market for Stem Cell Assays estimated at US$2.9 Billion in the year 2024, is expected to reach US$7.7 Billion by 2030, growing at a CAGR of 17.9% over the analysis period 2024-2030. Instruments, one of the segments analyzed in the report, is expected to record a 18.4% CAGR and reach US$6.1 Billion by the end of the analysis period. Growth in the Kits segment is estimated at 17.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$791.1 Million While China is Forecast to Grow at 16.4% CAGR

The Stem Cell Assays market in the U.S. is estimated at US$791.1 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.1 Billion by the year 2030 trailing a CAGR of 16.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 16.0% and 15.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 12.9% CAGR.

Global Stem Cell Assays Market - Key Trends and Drivers Summarized

How Are Stem Cell Assays Revolutionizing Drug Discovery and Development?

Stem cell assays have emerged as a crucial tool in the field of regenerative medicine, drug discovery, and development, offering insights into cellular behavior, differentiation, and potential therapeutic applications. These assays enable researchers to evaluate the potency, efficacy, and toxicity of drug candidates on stem cells, providing valuable data for preclinical studies. With the rising demand for personalized medicine and regenerative therapies, the use of stem cell assays is expanding rapidly in the pharmaceutical and biotechnology sectors. The ability of stem cell assays to model human diseases, predict drug responses, and screen for new therapeutic targets has made them indispensable for advancing next-generation treatments. Moreover, the adoption of stem cell assays in toxicity testing and high-throughput screening is driving their demand across research laboratories and contract research organizations (CROs).

What Technological Innovations Are Shaping the Future of Stem Cell Assays?

Technological advancements are significantly shaping the future of stem cell assays, enhancing their accuracy, reliability, and scalability. The integration of high-content screening (HCS), automated imaging, and data analytics is enabling the development of more sophisticated, robust, and reproducible stem cell assays. Innovations in 3D cell culture, organoids, and microfluidic systems are providing more physiologically relevant models that closely mimic in vivo conditions, improving the predictive power of stem cell assays. Additionally, the emergence of CRISPR-Cas9 gene editing technology and induced pluripotent stem cells (iPSCs) is expanding the scope of stem cell assays in studying genetic diseases, drug resistance, and cellular therapies. These innovations are driving the shift toward more efficient, high-throughput, and cost-effective assay platforms that can support the growing demand for precision medicine and targeted therapies.

Which Market Segments Are Leading the Growth of the Stem Cell Assays Industry?

Types of stem cell assays include viability/cytotoxicity assays, proliferation assays, differentiation assays, apoptosis assays, and others, with viability/cytotoxicity assays holding the largest market share due to their widespread use in drug toxicity testing and safety assessment. Applications of stem cell assays span drug discovery and development, regenerative medicine, clinical research, and toxicity testing, with drug discovery and development being a key segment due to the high demand for innovative and effective drug candidates. End-users of stem cell assays include pharmaceutical and biotechnology companies, academic and research institutes, and CROs, with pharmaceutical and biotechnology companies leading the market due to their significant investments in R&D and regenerative medicine. Geographically, North America, Europe, and Asia-Pacific are the largest markets for stem cell assays, driven by strong research infrastructure, government funding, and the growing focus on personalized medicine and cell-based therapies.

What Are the Key Drivers of Growth in the Stem Cell Assays Market?

The growth in the stem cell assays market is driven by several factors, including rising demand for regenerative medicine, personalized therapies, and targeted drug discovery, technological advancements in assay platforms, automation, and high-content screening, and the increasing adoption of stem cell assays in clinical trials, immunotherapy, and cancer research. The need to provide accurate, reproducible, and high-throughput solutions for various research and clinical applications is driving the demand for stem cell assays across multiple sectors. Technological innovations in 3D cell culture, organoids, gene editing, and data analytics, coupled with advancements in assay design, imaging, and multiplexing, are enhancing the performance, reliability, and marketability of stem cell assays, supporting market growth. The expansion of stem cell assay applications in neurobiology, cardiovascular research, infectious diseases, and toxicology, along with the growing emphasis on stem cell differentiation, characterization, and potency testing, is creating new opportunities for market players. Additionally, the focus on developing robust, cost-effective, and scalable stem cell assay solutions for diverse research needs is further propelling the growth of the stem cell assays market.

SCOPE OF STUDY:

The report analyzes the Stem Cell Assays market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Component (Instruments, Kits, Services); Type (Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function, Apoptosis); Cell Type (Adult Stem Cells, hESCs); Application (Regenerative Medicine, Clinical Research, Drug Discovery & Development)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 44 Featured) -

  • Antria, Inc.
  • Applied StemCell, Inc.
  • Beike Biotechnology Co., Ltd.
  • BioGenCell
  • BioRestorative Therapies
  • Bio-Techne Corporation
  • Celltex Therapeutics
  • Century Therapeutics
  • Cynata Therapeutics Ltd.
  • Forever Labs, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Global Economic Update
    • Stem Cell Assays - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Regenerative Medicine and Personalized Therapy Drives Adoption of Stem Cell Assays
    • Technological Advancements in High-Throughput Screening and Automation Propel Innovation in Stem Cell Assays
    • Increasing Use of Stem Cell Assays in Drug Discovery and Development Expands Addressable Market Opportunity
    • Focus on Predictive Toxicology and Disease Modeling Strengthens Business Case for Stem Cell Assays
    • Emergence of 3D Cell Culture and Organoid Models Enhances Applications of Stem Cell Assays
    • Rising Adoption of Stem Cell Assays in Clinical Trials, Immunotherapy, and Cancer Research Fuels Market Growth
    • Shift Toward High-Content Screening, Imaging, and Data Analytics Drives Market Adoption
    • Focus on Developing Robust, Reproducible, and Cost-Effective Stem Cell Assay Solutions Supports Market Competitiveness
    • Expansion of Stem Cell Assay Applications in Neurobiology, Cardiovascular, and Infectious Diseases Spurs Market Potential
    • Increasing Emphasis on Stem Cell Differentiation, Characterization, and Potency Testing Creates Market Opportunities
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Stem Cell Assays Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Stem Cell Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Stem Cell Assays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Viability / Cytotoxicity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Viability / Cytotoxicity by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Differentiation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Differentiation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Isolation & Purification by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Isolation & Purification by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Cell Identification by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Cell Identification by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Proliferation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Proliferation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Function by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Function by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Apoptosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Apoptosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Adult Stem Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 25: World 6-Year Perspective for Adult Stem Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for hESCs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World 6-Year Perspective for hESCs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Regenerative Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 29: World 6-Year Perspective for Regenerative Medicine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 30: World Recent Past, Current & Future Analysis for Clinical Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 31: World 6-Year Perspective for Clinical Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Drug Discovery & Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 33: World 6-Year Perspective for Drug Discovery & Development by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Stem Cell Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 34: USA Recent Past, Current & Future Analysis for Stem Cell Assays by Component - Instruments, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 35: USA 6-Year Perspective for Stem Cell Assays by Component - Percentage Breakdown of Value Sales for Instruments, Kits and Services for the Years 2025 & 2030
    • TABLE 36: USA Recent Past, Current & Future Analysis for Stem Cell Assays by Type - Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 37: USA 6-Year Perspective for Stem Cell Assays by Type - Percentage Breakdown of Value Sales for Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis for the Years 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Stem Cell Assays by Cell Type - Adult Stem Cells and hESCs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA 6-Year Perspective for Stem Cell Assays by Cell Type - Percentage Breakdown of Value Sales for Adult Stem Cells and hESCs for the Years 2025 & 2030
    • TABLE 40: USA Recent Past, Current & Future Analysis for Stem Cell Assays by Application - Regenerative Medicine, Clinical Research and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 41: USA 6-Year Perspective for Stem Cell Assays by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Clinical Research and Drug Discovery & Development for the Years 2025 & 2030
  • CANADA
    • TABLE 42: Canada Recent Past, Current & Future Analysis for Stem Cell Assays by Component - Instruments, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 43: Canada 6-Year Perspective for Stem Cell Assays by Component - Percentage Breakdown of Value Sales for Instruments, Kits and Services for the Years 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Stem Cell Assays by Type - Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada 6-Year Perspective for Stem Cell Assays by Type - Percentage Breakdown of Value Sales for Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis for the Years 2025 & 2030
    • TABLE 46: Canada Recent Past, Current & Future Analysis for Stem Cell Assays by Cell Type - Adult Stem Cells and hESCs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Canada 6-Year Perspective for Stem Cell Assays by Cell Type - Percentage Breakdown of Value Sales for Adult Stem Cells and hESCs for the Years 2025 & 2030
    • TABLE 48: Canada Recent Past, Current & Future Analysis for Stem Cell Assays by Application - Regenerative Medicine, Clinical Research and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Canada 6-Year Perspective for Stem Cell Assays by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Clinical Research and Drug Discovery & Development for the Years 2025 & 2030
  • JAPAN
    • Stem Cell Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Stem Cell Assays by Component - Instruments, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan 6-Year Perspective for Stem Cell Assays by Component - Percentage Breakdown of Value Sales for Instruments, Kits and Services for the Years 2025 & 2030
    • TABLE 52: Japan Recent Past, Current & Future Analysis for Stem Cell Assays by Type - Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Japan 6-Year Perspective for Stem Cell Assays by Type - Percentage Breakdown of Value Sales for Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis for the Years 2025 & 2030
    • TABLE 54: Japan Recent Past, Current & Future Analysis for Stem Cell Assays by Cell Type - Adult Stem Cells and hESCs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Japan 6-Year Perspective for Stem Cell Assays by Cell Type - Percentage Breakdown of Value Sales for Adult Stem Cells and hESCs for the Years 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Stem Cell Assays by Application - Regenerative Medicine, Clinical Research and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan 6-Year Perspective for Stem Cell Assays by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Clinical Research and Drug Discovery & Development for the Years 2025 & 2030
  • CHINA
    • Stem Cell Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 58: China Recent Past, Current & Future Analysis for Stem Cell Assays by Component - Instruments, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 59: China 6-Year Perspective for Stem Cell Assays by Component - Percentage Breakdown of Value Sales for Instruments, Kits and Services for the Years 2025 & 2030
    • TABLE 60: China Recent Past, Current & Future Analysis for Stem Cell Assays by Type - Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 61: China 6-Year Perspective for Stem Cell Assays by Type - Percentage Breakdown of Value Sales for Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis for the Years 2025 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Stem Cell Assays by Cell Type - Adult Stem Cells and hESCs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China 6-Year Perspective for Stem Cell Assays by Cell Type - Percentage Breakdown of Value Sales for Adult Stem Cells and hESCs for the Years 2025 & 2030
    • TABLE 64: China Recent Past, Current & Future Analysis for Stem Cell Assays by Application - Regenerative Medicine, Clinical Research and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 65: China 6-Year Perspective for Stem Cell Assays by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Clinical Research and Drug Discovery & Development for the Years 2025 & 2030
  • EUROPE
    • Stem Cell Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 66: Europe Recent Past, Current & Future Analysis for Stem Cell Assays by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 67: Europe 6-Year Perspective for Stem Cell Assays by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Stem Cell Assays by Component - Instruments, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe 6-Year Perspective for Stem Cell Assays by Component - Percentage Breakdown of Value Sales for Instruments, Kits and Services for the Years 2025 & 2030
    • TABLE 70: Europe Recent Past, Current & Future Analysis for Stem Cell Assays by Type - Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 71: Europe 6-Year Perspective for Stem Cell Assays by Type - Percentage Breakdown of Value Sales for Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis for the Years 2025 & 2030
    • TABLE 72: Europe Recent Past, Current & Future Analysis for Stem Cell Assays by Cell Type - Adult Stem Cells and hESCs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 73: Europe 6-Year Perspective for Stem Cell Assays by Cell Type - Percentage Breakdown of Value Sales for Adult Stem Cells and hESCs for the Years 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Stem Cell Assays by Application - Regenerative Medicine, Clinical Research and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe 6-Year Perspective for Stem Cell Assays by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Clinical Research and Drug Discovery & Development for the Years 2025 & 2030
  • FRANCE
    • Stem Cell Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 76: France Recent Past, Current & Future Analysis for Stem Cell Assays by Component - Instruments, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 77: France 6-Year Perspective for Stem Cell Assays by Component - Percentage Breakdown of Value Sales for Instruments, Kits and Services for the Years 2025 & 2030
    • TABLE 78: France Recent Past, Current & Future Analysis for Stem Cell Assays by Type - Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 79: France 6-Year Perspective for Stem Cell Assays by Type - Percentage Breakdown of Value Sales for Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis for the Years 2025 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Stem Cell Assays by Cell Type - Adult Stem Cells and hESCs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France 6-Year Perspective for Stem Cell Assays by Cell Type - Percentage Breakdown of Value Sales for Adult Stem Cells and hESCs for the Years 2025 & 2030
    • TABLE 82: France Recent Past, Current & Future Analysis for Stem Cell Assays by Application - Regenerative Medicine, Clinical Research and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 83: France 6-Year Perspective for Stem Cell Assays by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Clinical Research and Drug Discovery & Development for the Years 2025 & 2030
  • GERMANY
    • Stem Cell Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 84: Germany Recent Past, Current & Future Analysis for Stem Cell Assays by Component - Instruments, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Germany 6-Year Perspective for Stem Cell Assays by Component - Percentage Breakdown of Value Sales for Instruments, Kits and Services for the Years 2025 & 2030
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Stem Cell Assays by Type - Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Germany 6-Year Perspective for Stem Cell Assays by Type - Percentage Breakdown of Value Sales for Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis for the Years 2025 & 2030
    • TABLE 88: Germany Recent Past, Current & Future Analysis for Stem Cell Assays by Cell Type - Adult Stem Cells and hESCs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Germany 6-Year Perspective for Stem Cell Assays by Cell Type - Percentage Breakdown of Value Sales for Adult Stem Cells and hESCs for the Years 2025 & 2030
    • TABLE 90: Germany Recent Past, Current & Future Analysis for Stem Cell Assays by Application - Regenerative Medicine, Clinical Research and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Germany 6-Year Perspective for Stem Cell Assays by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Clinical Research and Drug Discovery & Development for the Years 2025 & 2030
  • ITALY
    • TABLE 92: Italy Recent Past, Current & Future Analysis for Stem Cell Assays by Component - Instruments, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Italy 6-Year Perspective for Stem Cell Assays by Component - Percentage Breakdown of Value Sales for Instruments, Kits and Services for the Years 2025 & 2030
    • TABLE 94: Italy Recent Past, Current & Future Analysis for Stem Cell Assays by Type - Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Italy 6-Year Perspective for Stem Cell Assays by Type - Percentage Breakdown of Value Sales for Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis for the Years 2025 & 2030
    • TABLE 96: Italy Recent Past, Current & Future Analysis for Stem Cell Assays by Cell Type - Adult Stem Cells and hESCs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 97: Italy 6-Year Perspective for Stem Cell Assays by Cell Type - Percentage Breakdown of Value Sales for Adult Stem Cells and hESCs for the Years 2025 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Stem Cell Assays by Application - Regenerative Medicine, Clinical Research and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Italy 6-Year Perspective for Stem Cell Assays by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Clinical Research and Drug Discovery & Development for the Years 2025 & 2030
  • UNITED KINGDOM
    • Stem Cell Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 100: UK Recent Past, Current & Future Analysis for Stem Cell Assays by Component - Instruments, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 101: UK 6-Year Perspective for Stem Cell Assays by Component - Percentage Breakdown of Value Sales for Instruments, Kits and Services for the Years 2025 & 2030
    • TABLE 102: UK Recent Past, Current & Future Analysis for Stem Cell Assays by Type - Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 103: UK 6-Year Perspective for Stem Cell Assays by Type - Percentage Breakdown of Value Sales for Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis for the Years 2025 & 2030
    • TABLE 104: UK Recent Past, Current & Future Analysis for Stem Cell Assays by Cell Type - Adult Stem Cells and hESCs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: UK 6-Year Perspective for Stem Cell Assays by Cell Type - Percentage Breakdown of Value Sales for Adult Stem Cells and hESCs for the Years 2025 & 2030
    • TABLE 106: UK Recent Past, Current & Future Analysis for Stem Cell Assays by Application - Regenerative Medicine, Clinical Research and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 107: UK 6-Year Perspective for Stem Cell Assays by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Clinical Research and Drug Discovery & Development for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 108: Rest of Europe Recent Past, Current & Future Analysis for Stem Cell Assays by Component - Instruments, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 109: Rest of Europe 6-Year Perspective for Stem Cell Assays by Component - Percentage Breakdown of Value Sales for Instruments, Kits and Services for the Years 2025 & 2030
    • TABLE 110: Rest of Europe Recent Past, Current & Future Analysis for Stem Cell Assays by Type - Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Rest of Europe 6-Year Perspective for Stem Cell Assays by Type - Percentage Breakdown of Value Sales for Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis for the Years 2025 & 2030
    • TABLE 112: Rest of Europe Recent Past, Current & Future Analysis for Stem Cell Assays by Cell Type - Adult Stem Cells and hESCs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 113: Rest of Europe 6-Year Perspective for Stem Cell Assays by Cell Type - Percentage Breakdown of Value Sales for Adult Stem Cells and hESCs for the Years 2025 & 2030
    • TABLE 114: Rest of Europe Recent Past, Current & Future Analysis for Stem Cell Assays by Application - Regenerative Medicine, Clinical Research and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 115: Rest of Europe 6-Year Perspective for Stem Cell Assays by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Clinical Research and Drug Discovery & Development for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Stem Cell Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Stem Cell Assays by Component - Instruments, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Asia-Pacific 6-Year Perspective for Stem Cell Assays by Component - Percentage Breakdown of Value Sales for Instruments, Kits and Services for the Years 2025 & 2030
    • TABLE 118: Asia-Pacific Recent Past, Current & Future Analysis for Stem Cell Assays by Type - Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 119: Asia-Pacific 6-Year Perspective for Stem Cell Assays by Type - Percentage Breakdown of Value Sales for Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis for the Years 2025 & 2030
    • TABLE 120: Asia-Pacific Recent Past, Current & Future Analysis for Stem Cell Assays by Cell Type - Adult Stem Cells and hESCs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 121: Asia-Pacific 6-Year Perspective for Stem Cell Assays by Cell Type - Percentage Breakdown of Value Sales for Adult Stem Cells and hESCs for the Years 2025 & 2030
    • TABLE 122: Asia-Pacific Recent Past, Current & Future Analysis for Stem Cell Assays by Application - Regenerative Medicine, Clinical Research and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Asia-Pacific 6-Year Perspective for Stem Cell Assays by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Clinical Research and Drug Discovery & Development for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 124: Rest of World Recent Past, Current & Future Analysis for Stem Cell Assays by Component - Instruments, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 125: Rest of World 6-Year Perspective for Stem Cell Assays by Component - Percentage Breakdown of Value Sales for Instruments, Kits and Services for the Years 2025 & 2030
    • TABLE 126: Rest of World Recent Past, Current & Future Analysis for Stem Cell Assays by Type - Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 127: Rest of World 6-Year Perspective for Stem Cell Assays by Type - Percentage Breakdown of Value Sales for Viability / Cytotoxicity, Differentiation, Isolation & Purification, Cell Identification, Proliferation, Function and Apoptosis for the Years 2025 & 2030
    • TABLE 128: Rest of World Recent Past, Current & Future Analysis for Stem Cell Assays by Cell Type - Adult Stem Cells and hESCs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of World 6-Year Perspective for Stem Cell Assays by Cell Type - Percentage Breakdown of Value Sales for Adult Stem Cells and hESCs for the Years 2025 & 2030
    • TABLE 130: Rest of World Recent Past, Current & Future Analysis for Stem Cell Assays by Application - Regenerative Medicine, Clinical Research and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 131: Rest of World 6-Year Perspective for Stem Cell Assays by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Clinical Research and Drug Discovery & Development for the Years 2025 & 2030

IV. COMPETITION